Immunohistochemical Expression of CD 133 in Colorectal Adenocarcinomas and their Corresponding Lymph Node Metastases

Volume 20 No 6 (2022)

Mina E. Attya , Nisreen Abdel Tawab Abdel Gaber Osman , Dalia Mohamed Abd-El Rehim , Heba Mohamed Tawfik , Reda Fikry Abdel Meguid

DOI: 10.14704/nq.2022.20.6.NQ22349

Abstract

Colorectal cancer (CRC) occupies the third order among commonest cancers worldwide. In Egypt, it ranks the 7th common cancer. CD 133 is a cancer stem cell marker which is correlated with several poor prognostic factors in various types of human cancers. In the present study, we explored the immunohisochemical expression of CD 133 in colorectal adenocarcinoma and its association with various clinicopathological features.

Keywords

CRC, Lymph Node Metastasis, CD 133, Immunohistochemistry, Clinicopathological Features.

Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.